ليست عنوان مقالات لاتين Droperidol and the black box warning Drugs and personal care products as ubiquitous pollutants: occurrence and distribution of clofibric acid, caffeine and DEET in the North Sea

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

Droperidol and the black box warning

2

Droperidol for acute migraine headache

3

Droperidol for the treatment of acute peripheral vertigo

4

Droperidol, QT prolongation, and sudden death: What is the evidence?

5

Drop-in energy performance evaluation of R1234yf and R1234ze(E) in a vapor compression system as R134a replacements

6

Drop-in replacement of R22 in heat pumps used for district heating — influence of equipment and property limitations

7

Droplet and Particle Dynamics during Flame Spray Synthesis of Nanoparticles

8

Droplet bounce simulations and air pressure effects on the deformation of pre-impact droplets, using a boundary element method

9

Droplet Breakdown Analysis inside Porous Media at Different Porosities, Using LBM

10

Droplet breakup and coalescence in a twin-screw extrusion processing of starch based matrix Original Research Article

11

Droplet breakup and viscosity-stratified flows in microchannels

12

Droplet breakup in subsea oil releases – Part 2: Predictions of droplet size distributions with and without injection of chemical dispersants

13

Droplet breakup in subsurface oil releases – Part 1: Experimental study of droplet breakup and effectiveness of dispersant injection

14

Droplet breakup phenomena in flows with velocity lag

15

Droplet characterization and stability of soybean oil/palm kernel olein O/W emulsions with the presence of selected polysaccharides

16

Droplet charging by high voltage discharges and its influence on precipitation enhancement

17

Droplet coalescence by geometrically mediated flow in microfluidic channels

18

Droplet collision processes in an inter-spray impingement system

19

Droplet combustion experiments in varying forced convection using microgravity environment

20

Droplet combustion in presence of airstream oscillation: Mechanisms of enhancement and hysteresis of burning rate in microgravity at elevated pressure

21

Droplet combustion in the presence of acoustic excitation

22

Droplet combustion of blended fuels with alcohol and biodiesel/diesel in microgravity condition

23

Droplet combustion studies of hydrocarbon-monopropellant blends

24

Droplet concentration (LWC) and its chemical composition after gas cleaning in the lignite fired power plant Ja¨nschwalde (FRG)

25

Droplet condensation on polymer surfaces: a review

26

Droplet cooling in atomization sprays

27

Droplet Counter Current Chromatography (DCCC) in herbal analysis

28

Droplet creation using liquid dielectrophoresis

29

Droplet deformation and break-up under shear: Hydrocolloid solution vs. suspension of starch granules

30

Droplet deformation under confined Poiseuille flow

31

Droplet deposition measurement with high-speed camera and novel high-speed liquid film sensor with high spatial resolution

32

Droplet detachment in cross-flow membrane emulsification: Comparison among torque- and force-based models

33

Droplet detachment regimes in annular laser beam droplet generation from a metal wire

34

Droplet dispersion in chemical fogs

35

DROPLET DISTORTION IN ACCELERATING FLOW

36

Droplet dynamics in a bifurcating channel

37

Droplet emission from liquid metal ion sources and their disintegration

38

Droplet emission from liquid metal ion sources and their disintegration

39

Droplet erosion performance of composite materials electroplated with a hard metal layer

40

Droplet evaporation and condensation in the near-continuum regime

41

Droplet evaporation and de-pinning in rectangular microchannels

42

Droplet evaporation characteristics due to wet compression under RCM conditions

43

Droplet evaporation from porous surfaces; model validation from field and wind tunnel experiments for sand and concrete

44

Droplet evaporation modeling by the distillation curve model: accounting for kerosene fuel and elevated pressures

45

Droplet evaporation with reference to the effectiveness of water-mist cooling

46

Droplet formation during laser sputtering of silicon

47

Droplet formation from a pulsed vibrating micro-nozzle

48

Droplet formation in a T-shaped microchannel junction: A model system for membrane emulsification

49

Droplet formation in cold asymmetric nuclear matter in the quark-meson-coupling model

50

Droplet formation in cold asymmetric nuclear matter in the quark–meson-coupling model Original Research Article

51

Droplet formation on metallic surfaces during low-fluence laser irradiation

52

Droplet Formation, Detachment, and Impingement on the Molten Pool in Gas Metal Arc Welding

53

Droplet Formation, Detachment, and Impingement on the Molten Pool in Gas Metal Arc Welding

54

Droplet fractionation of hexavalent chromium from bubbles bursting at liquid surfaces of chromic acid solutions

55

Droplet generation from pulsed micro-jets

56

Droplet growth for three-dimensional Kawasaki dynamics

57

Droplet growth in a bin warm-rain scheme with Twomey CCN activation

58

Droplet growth in gas flows by condensation - experimental and theoretical growth curves

59

Droplet heat and mass transfer in a turbulent hot airstream

60

Droplet hysteresis investigation on non-wetting striped textured surfaces: A lattice Boltzmann study

61

Droplet ignition and combustion including liquid-phase heating

62

Droplet ignition in a high-temperature convective environment

63

Droplet impact and spreading on lecithinated anhydrous milkfat surfaces Original Research Article

64

Droplet interactions in creeping flow

65

Droplet interfacial structure studied by SANS contrast variation

66

Droplet lasing spectroscopy applied to droplet stream flames

67

Droplet mass transfer, intradroplet nucleation and submicron particle production in two-phase flow of solvent-supercritical antisolvent emulsion

68

Droplet model of an atomic cluster at a solid surface

69

Droplet nucleation and growth in orographic clouds in relation to the aerosol population

70

Droplet oscillations driven by an electric field

71

Droplet pinning by PEM fuel cell GDL surfaces

72

Droplet population balance modelling--hydrodynamics and mass transfer

73

Droplet printing through bubble contact in the laser forward transfer of liquids

74

Droplet production from disintegrating bubbles at water surfaces. Single vs. multiple bubbles

75

Droplet retention on an incline

76

Droplet size and composition of nutraceutical nanoemulsions influences bioavailability of long chain fatty acids and Coenzyme Q10

77

Droplet size and stability of nano-emulsions produced by the temperature phase inversion method

78

Droplet size and transmittance spectra of mechanically generated water fogs

79

Droplet size and velocity distributions for spray modelling

80

Droplet size control in the filter expansion aerosol generator

81

Droplet size determination in food emulsions: comparison of ultrasonic and light scattering methods

82

Droplet size distribution and evaporation characteristics of fuel spray by a swirl type atomizer

83

Droplet Size Distributions as a function of rainy system type and Cloud Condensation Nuclei concentrations

84

Droplet size measurements in horizontal annular gas–liquid flow

85

Droplet size spectra and drift effect of two phenmedipham formulations and four adjuvants mixtures

86

Droplet sizing using silicone oils

87

Droplet spreading: a tool to characterize surfaces at the microscopic scale

88

Droplet transport in oil/gas and water/gas flow at high gas densities

89

Droplet vaporisation characteristics of vegetable oil derived biofuels at high temperatures

90

Droplet vaporization model in the presence of thermal radiation

91

Droplet vaporization modeling of rapeseed and sunflower methyl esters

92

Droplet-based microdialysis—Concept, theory, and design considerations

93

Droplet-based microextraction in the aqueous two-phase system

94

Droplet-based microfluidic lab-on-a-chip for glucose detection

95

Droplet-based microfluidic lab-on-a-chip for glucose detection Original Research Article

96

Droplet-Based Microfluidic Platforms for the Encapsulation and Screening of Mammalian Cells and Multicellular Organisms

97

Droplet-Based Microfluidic Platforms for the Encapsulation and Screening of Mammalian Cells and Multicellular Organisms Original Research Article

98

Droplet-based microfluidic sensing system for rapid fish freshness determination

99

Droplet-based microfluidics for dose–response assay of enzyme inhibitors by electrochemical method Original Research Article

100

Droplet-based microscale colorimetric biosensor for multiplexed DNA analysis via a graphene nanoprobe Original Research Article

101

Droplet-based synthetic method using microflow focusing and droplet fusion

102

Dropletde-entrainmentbyinertialimpactiononverticalrodsinanair-dropletmixtureflowOriginalResearchArticle

103

Dropletentrainmentcorrelationinverticalupwardco-currentannulartwo-phaseflowOriginalResearchArticle

104

Droplet-free TiC nanocrystal-containing diamond-like carbon coatings deposited by combined cathodic arc MF magnetron sputtering

105

Droplet-induced anomalous deformation of a thin micro-plate

106

Droplets formation in turbulent mixing of two immiscible fluids in a new type of static mixer

107

Droplets from the metal surfaces irradiated by a high-intensity pulsed ion beam

108

Droplets profiles and wetting transitions in electric fields

109

Droplets Tracing in a T-junction Microchannel

110

DropletsdepositioninsteampipingconnectingsteamgeneratorandsteamturbineinnuclearplantOriginalResearchArticle

111

Droplet-size dependence of the electron transfer rate across the single-microdroplet/water interface

112

Drop-off during ribosome hopping

113

Drop-on-demand deposition of superheated metal droplets for selective infiltration manufacturing

114

Drop-on-demand deposition of superheated metal droplets for selective infiltration manufacturing

115

Drop-on-demand drop formation of colloidal suspensions

116

Drop-on-demand printing of cells and materials for designer tissue constructs

117

Dropout Analysis of a National Social Health Insurance Program at Pokhara Metropolitan City, Kaski, Nepal

118

Dropout and early unemployment

119

Dropout from outpatient mental health care: results from the Israel National Health Survey

120

Drop-out from primary schools in tribal India: A case study of the Ho in Parampancho, West Singhbhum

121

Dropout from Rehabilitation and Its Associated Factors in Children with Developmental Disabilities in Tehran Rehabilitation Centers

122

Dropout Prediction and Reduction in Distance Education Courses with the Learning Analytics Multitrail Approach

123

Dropout rate and associated factors in patients with bipolar disorders

124

Dropout rate for intent-to-treat and per protocol analye

125

DROPOUT STEREOTYPE AND TRANSFORMATION OF ORANG KUALA S ORANG ASLI: A REVIEW ON THE ADAPTATION OF THE NEW HUMAN CAPITAL

126

Dropouts and Social Determinants of Health; Policy for the Prevention of School Dropout, Qualitative Study of the Causes and Interventions

127

Drop-outs in tamoxifen prevention trials

128

Drop-outs in tamoxifen prevention trials

129

Dropouts Problem among Karnataka (India) Tribal Children: Where Rubber hits the Road?

130

Dropouts versus completers among chronically depressed outpatients

131

Dropped Gallstones Causing Transdiaphragmatic Migration and Thoracic Empyema

132

Dropped head syndrome after radiotherapy for lymphoma: A report of three cases

133

Dropped Head Syndrome in a Patient with Aeromonas hydrophila-induced Septic Arthritis of the Shoulder

134

Dropped-head and bent-spine syndromes; axial myopathies?

135

Dropping out of mental health treatment among patients with depression and anxiety by type of provider: results of the European Study of the Epidemiology of Mental Disorders

136

Dropping out of school: A review of intervention programs

137

Dropping rates of elaiosome-bearing seeds during transport by ants (Formica polyctena Foerst.): Implications for distance dispersal

138

Dropping the weight stigma: Nostalgia improves attitudes toward persons who are overweight

139

Dropping variables versus use of proxy variables in linear regression

140

Drops deformation and magnetic permeability of a ferrofluid emulsion

141

Drops that pull themselves up

142

Drop-Size Analysis in a Two-Phase Reactive Liquid-Liquid System on a Bubble-Cap Tray

143

Dropstones, pseudoplanktonic forms and deep-water decapod crustaceans within a Lutetian condensed succession of central Istria (Croatia): relation to palaeoenvironmental evolution and palaeogeography

144

Dropstones: their origin and significance

145

Dropstones: their origin and significance: a comment

146

Drop-to-drop microextraction across a supported liquid membrane by an electrical field under stagnant conditions

147

Drop-weight test based identification of elastic half-space model parameters

148

Dropwise condensation from flowing air–steam mixtures: Diffusion resistance assessed by controlled drainage

149

Dropwise condensation heat transfer on ion implanted aluminum surfaces

150

DROPWISE CONDENSATION OF STEAM ON A SMALL TUBE BUNDLE AT TURBINE CONDENSER CONDITIONS

151

DROPWISE CONDENSATION OF STEAM ON A SMALL TUBE BUNDLE AT TURBINE CONDENSER CONDITIONS AN EXPERIMENTAL STUDY OF THE TWO-PHASE FLOW ADJACENT TO A WIRE IN NUCLEATE BOILING UNDER AN ELECTRIC FIELD

152

Dropwise condensation of steam on ion implanted titanium surfaces

153

Dropwise condensation on L-B film surface

154

Dropwise condensation rate of water breath figures on polymer surfaces having similar surface free energies

155

Dropwise cooling: Experimental tests by infrared thermography and numerical simulations

156

Dropwise deposition and wetting of nanoparticle suspensions

157

Drosophila Atrophin Homolog Functions as a Transcriptional Corepressor in Multiple Developmental Processes

158

Drosophila Auditory Organ Genes and Genetic Hearing Defects

159

Drosophila BAP60 is an Essential Component of the Brahma Complex, Required for Gene Activation and Repression

160

Drosophila BTB/POZ Domains of “ttk Group” Can Form Multimers and Selectively Interact with Each Other

161

Drosophila Calmodulin Mutants With Specific Defects in the Musculature or in the Nervous System

162

Drosophila Checkpoint Kinase 2 Couples Centrosome Function and Spindle Assembly to Genomic Integrity

163

Drosophila Clock Can Generate Ectopic Circadian Clocks

164

Drosophila cohesins DSA1 and Drad21 persist and colocalize along the centromeric heterochromatin during mitosis

165

Drosophila cryb mutation reveals two circadian clocks that drive locomotor rhythm and have different responsiveness to light

166

Drosophila CTCF Is Required for Fab-8 Enhancer Blocking Activity in S2 Cells

167

Drosophila Cytokine Unpaired 2 Regulates Physiological Homeostasis by Remotely Controlling Insulin Secretion

168

Drosophila DPM Neurons Form a Delayed and Branch-Specific Memory Trace after Olfactory Classical Conditioning

169

Drosophila Dscam Is an Axon Guidance Receptor Exhibiting Extraordinary Molecular Diversity

170

Drosophila Dumbfounded: A Myoblast Attractant Essential for Fusion

171

Drosophila Enhancer of Zeste/ESC Complexes Have a Histone H3 Methyltransferase Activity that Marks Chromosomal Polycomb Sites

172

Drosophila fasciclinII Is Required for the Formation of Odor Memories and for Normal Sensitivity to Alcohol

173

Drosophila female precopulatory behavior is modulated by ecdysteroids

174

Drosophila Fragile X-Related Gene Regulates the MAP1B Homolog Futsch to Control Synaptic Structure and Function

175

Drosophila Gain-of-Function Mutant RTK Torso Triggers Ectopic Dpp and STAT Signaling

176

Drosophila genome sequence, a model for the human

177

Drosophila Genome-wide Obesity Screen Reveals Hedgehog as a Determinant of Brown versus White Adipose Cell Fate

178

Drosophila gustatory receptors: from gene identification to functional expression

179

Drosophila immunity: paths and patterns

180

Drosophila immunity: two paths to NF-κB

181

Drosophila male courtship behavior is modulated by ecdysteroids

182

Drosophila males transfer antibacterial proteins from their accessory gland and ejaculatory duct to their mates

183

Drosophila melanogaster and D. simulans rescue strains produce fit offspring, despite divergent centromerespecific histone alleles

184

Drosophila melanogaster as a Model to Study Human Neurodegenerative Diseases

185

Drosophila melanogaster Laboratory Rearing for Wolbachia-Based Control Programs, a Component of Dengue Control

186

Drosophila melanogaster males increase the number of sperm in their ejaculate when perceiving rival males

187

Drosophila melanogaster Methoprene-tolerant (Met) gene homologs from three mosquito species: Members of PAS transcriptional factor family

188

Drosophila melanogaster syncytial nuclear divisions are patterned: time-lapse images, hypothesis and computational evidence

189

Drosophila microRNAs Are Sorted into Functionally Distinct Argonaute Complexes after Production by Dicer-1

190

Drosophila model increases understanding of fragile-X syndrome

191

Drosophila Myc Regulates Organ Size by Inducing Cell Competition

192

Drosophila neural progenitor polarity and asymmetric division

193

Drosophila Neuroblasts Sequentially Express Transcription Factors which Specify the Temporal Identity of Their Neuronal Progeny

194

Drosophila p53 Binds a Damage Response Element at the reaper Locus

195

Drosophila p53 Is a Structural and Functional Homolog of the Tumor Suppressor p53

196

Drosophila PAR-1 and 14-3-3 Inhibit Bazooka/PAR-3 to Establish Complementary Cortical Domains in Polarized Cells

197

Drosophila Proteasome Regulator REGγ: Transcriptional Activation by DNA Replication-related Factor DREF and Evidence for a Role in Cell Cycle Progression

198

Drosophila Replication and Repair Proteins: Proliferating Cell Nuclear Antigen (PCNA)

199

Drosophila Rho-Associated Kinase (Drok) Links Frizzled-Mediated Planar Cell Polarity Signaling to the Actin Cytoskeleton

200

Drosophila Rhomboid-1 Defines a Family of Putative Intramembrane Serine Proteases

201

Drosophila serpin 27A is a likely target for immune suppression of the blood cell-mediated melanotic encapsulation response

202

Drosophila Sir2 Is Required for Heterochromatic Silencing and by Euchromatic Hairy/E(Spl) bHLH Repressors in Segmentation and Sex Determination

203

Drosophila song as a species-specific mating signal and the behavioural importance of Kyriacou & Hall cycles in D. melanogaster song

204

Drosophila still flying high in cancer research

205

Drosophila Tsc1 Functions with Tsc2 to Antagonize Insulin Signaling in Regulating Cell Growth, Cell Proliferation, and Organ Size

206

Drosophila Tufted Is a Gain-of-Function Allele of the Proneural Gene amos

207

Drosophila wingless and Pair-Rule Transcripts Localize Apically by Dynein-Mediated Transport of RNA Particles

208

Drosophila Zinc Finger Protein CG9890 Is Colocalized with Chromatin Modifying and Remodeling Complexes on Gene Promoters and Involved in Transcription Regulation

209

Dross formation during remelting of aluminum 5182 remelt secondary ingot (RSI)

210

Dross formation during remelting of aluminum 5182 remelt secondary ingot (RSI)

211

Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial

212

Drought 2002 in Colorado: An Unprecedented Drought or a Routine Drought?

213

Drought acclimation and lipid composition in Folsomia candida: implications for cold shock, heat shock and acute desiccation stress

214

Drought acclimation confers cold tolerance in the soil collembolan Folsomia candida

215

Drought adaptations in wild barley (Hordeum spontaneum) grown in Iran

216

Drought affects the fluxes of carbon to roots and soil in 13C pulse-labelled plants of wheat

217

Drought affects the fluxes of carbon to roots and soil in 13C pulse-labelled plants of wheat

218

Drought Allocations Using the Systems Impact Assessment Model: Klamath River

219

Drought alters respired δ13CO2 from autotrophic, but not heterotrophic soil respiration

220

Drought alters respired δ13CO2 from autotrophic, but not heterotrophic soil respiration

221

Drought analysis in the Lakes of Iran (Case study: Lake Urmia and Gavkhuni Swamp)

222

Drought and Aquatic Ecosystems: Effects and Responses, P. Sam Lake. Wiley-Blackwell, Oxford, Chichester, Hoboken (2011). xiv+381 pp., Price £55.00, Paperback, ISBN: 978-1-4051-8560-8 (also four electronic formats)

223

Drought and climatic change impact on streamflow in small watersheds Original Research Article

224

Drought and clipping effects on tiller demography andgrowth of two tussock grasses in Utah

225

Drought and declining reservoirs: Comparing media discourse in Arizona and New Mexico, 2002–2004

226

Drought and disputes, deluge and dearth: climatic variability and human response in colonial Oaxaca, Mexico

227

Drought and ecosystem carbon cycling

228

Drought and flood signals in subtropical estuaries recorded by stable isotope ratios in bivalve shells

229

Drought and grazing patch dynamics under different grazing management

230

Drought and malaria retreat in the Sahel, West Africa

231

Drought and Salinity Impacts on Bread Wheat in a Hydroponic Culture: A Physiological Comparison

232

Drought and salt tolerance enhancement of transgenic Arabidopsis by overexpression of the vacuolar pyrophosphatase 1 (EVP1) gene from Eucalyptus globulus

233

Drought and saving in West Africa: are livestock a buffer stock?

234

Drought and spring cooling induced recent decrease in vegetation growth in Inner Asia

235

Drought and the Impact of Natural Saline River on the Quality of Surface Water Resources In Karoon River(IRAN)

236

Drought changes the dynamics of trace element accumulation in a Mediterranean Quercus ilex forest

237

Drought class transition analysis through Markov and Loglinear models, an approach to early warning

238

Drought constraints on transpiration and canopy conductance in mature aspen and jack pine stands

239

Drought decreases soil enzyme activity in a Mediterranean Quercus ilex L. forest

240

Drought decreases soil enzyme activity in a Mediterranean Quercus ilex L. forest

241

Drought disturbance from climate change: response of United States forests

242

Drought duration and frequency in the U.S. Corn Belt during the last millennium (AD 992–2004)

243

Drought early warning system in reservoir operation: Theory and practice

244

Drought effects on elongation kinetics and sugar deposition in the elongation zone of durum wheat (Triticum durum Desf.) leaves

245

Drought effects on the early development stages of Panicum virgatum L.: Cultivar differences

246

Drought effects on water relations in beech: The contribution of exchangeable water reservoirs

247

DROUGHT EFFECTS ON YIELD TRAITS OF SOME SUNFLOWER INBRED LINES

248

Drought evolution at various time scales in the lowland regions and their impact on vegetable crops in the Czech Republic

249

Drought experiments within the Solling roof project

250

Drought Flow from Hillslope

251

Drought Flow from Hillslope

252

Drought forecasting based on the remote sensing data using ARIMA models

253

Drought forecasting using feed-forward recursive neural network

254

Drought forecasting using feed-forward recursive neural network

255

Drought forecasting using the Standardized Precipitation Index

256

Drought frequency analysis using cluster analysis and bivariate probability distribution

257

Drought identification and characterization in Jordan

258

Drought impacts on the water quality of freshwater systems; review and integration

259

Drought in groundwater—drought distribution and performance indicators

260

Drought induced pulses of image from a Canadian shield wetland: use of δ34S and δ18O in image to determine sources of sulfur

261

Drought is a major yield loss factor for rainfed East African highland banana

262

Drought mitigation using operative indicators in complex water systems

263

Drought modeling – A review

264

Drought Monitoring and Corn Yield Estimation in Southern Africa from AVHRR Data

265

Drought Monitoring and Prediction using K-Nearest Neighbor Algorithm

266

Drought Monitoring Based on the SPI and RDI Indices under Climate Change Scenarios (Case Study: Semi-Arid Areas of West Golestan Province)

267

Drought monitoring in Iran using the perpendicular drought indices

268

Drought Monitoring in Southern Coasts of Iran

269

Drought monitoring using a Soil Wetness Deficit Index (SWDI) derived from MODIS satellite data

270

Drought Monitoring Using Climatic Indices and Geostatistic Technique (Case Study: Hossein Abad Plain, Sarbisheh, Iran)

271

Drought Monitoring Using MODIS Land Surface Temperature and Normalized Difference Vegetation Index Products in Semi-Arid Areas of Iran

272

Drought Monitoring Using Vegetation Indices and MODIS Data (Case Study: Isfahan Province, Iran)

273

Drought Occurrence Pattern in Tigray Region, Northern Ethiopia

274

Drought Occurrence Probabilities and Risks of Dependent Hydrologic Processes

275

Drought planning and water allocation: an assessment of local capacity in Minnesota

276

Drought prediction using the Along Track Scanning Radiometer (ATSR2) on board ERS2 satellite Original Research Article

277

Drought probabilities and return period for annual streamflows series

278

Drought resistance of 2-year-old saplings of Mediterranean forest trees in the field: relations between water relations, hydraulics and productivity

279

Drought response of two bedding plants

280

Drought responses of Arrhenatherum elatius grown in plant assemblages of varying species richness

281

Drought Risk Assessment In Iraq Using Remote Sensing And GIS Techniques

282

Drought Risk Assessment in Western Inner-Mongolia

283

Drought Risk Assessment: A Case Study in Punjab, Pakistan

284

Drought risk management in agricultural sector with an emphasis on the socioeconomic dimension under Fuzzy Logic in the Sistan region

285

Drought Risk Vulnerability Parameters among Wheat

286

Drought Scenario Analysis Using RiverWare: A Case Study in Urumqi River Basin, China

287

Drought signals in tree-ring stable oxygen isotope series of Qilian juniper from the arid northeastern Tibetan Plateau

288

Drought stress and fluctuating asymmetry in Quercus undulata leaves: confounding effects of absolute and relative amounts of stress?

289

Drought Stress Effect on germination and Seedling Growth Indices in 5 Sugar Beet Genotypes

290

Drought stress effect on some phonological traits of advanced lines of bread wheat

291

Drought stress has contrasting effects on antioxidant enzymes activity and phenylpropanoid biosynthesis in Fraxinus ornus leaves: An excess light stress affair?

292

Drought Stress Impact on Some Biochemical and Physiological Traits of 4 Groundcovers (Lolium perenne, Potentilla spp, Trifolium repens and Frankinia spp) with Potential Landscape Usage

293

Drought Stress in Iranian Endemic Savory (Satureja rechingeri): In vivo and In vitro Studies

294

DROUGHT STRESS INCREASES THE EXPRESSION OF WHEAT LEAF RIBULOSE- 1, 5- BISPHOSPHATE CARBOXYLASE/OXYENASE PROTEIN

295

Drought stress tolerance based on selection indices of resistant crops variety

296

Drought stress tolerance of barley (Hordeum vulgare L.) affected by priming with PEG

297

Drought stress, plant water status, and floral trait expression in fireweed, Epilobium angustifolium (Onagraceae)

298

Drought Stress: A Review

299

Drought Stress-Induced Changes at Physiological and Biochemical Levels in Some Common Vetch (Vicia sativa L.) Genotypes

300

Drought stress-induced compositional changes in tolerant transgenic rice and its wild type

301

Drought stress-induced upregulation of components involved in ferredoxin-dependent cyclic electron transfer

302

Drought threatened semi-arid ecosystems in the Inner Asia

303

Drought tolerance associated with vertical stratification of two co-occurring epiphytic bromeliads in a tropical dry forest

304

Drought Tolerance in Cultivated and Wild Barley Genotypes: The Role of Root System Characteristics

305

Drought Tolerance is Associated with Rooting Depth and Stomatal Control of Water Use in Clones of Coffea canephora

306

Drought Tolerance of Selected Eragrostis Species Correlates with Leaf Tensile Properties

307

Drought Tolerance Screening in Thirty Common Wheat (Triticum aestivum L.) Genotypes

308

Drought tolerance through overexpression of monoubiquitin in transgenic tobacco

309

Drought tolerance through over-expression of the expansin gene TaEXPB23 in transgenic tobacco

310

Drought tolerance, phosphorus efficiency and yield characters of upland rice lines

311

DROUGHT TOLERANT WHEAT CULTIVAR (RAJ) FOR RAINFED AREAS OF KPK, PAKISTAN

312

Drought Utilization Management of Surface and Ground Water (Case study: Qaryat-Al-Arab Watershed)

313

Drought variability and its climatic implications

314

Drought variation trends in different subregions of the Chinese Loess Plateau over the past four decades

315

Drought vulnerability assessment: The case of wheat farmers in Western Iran

316

Drought vulnerability drives land-use and land cover changes in the Rift Valley dry lands of Ethiopia

317

Drought year changes in streambank profiles on incised streams in the Sierra Nevada Mountains

318

Drought, Abscisic Acid and Transpiration Rate Effects on the Regulation of PIP Aquaporin Gene Expression and Abundance in Phaseolus vulgaris Plants

319

Drought, but not salinity, determines the apparent effectiveness of halophytes colonized by arbuscular mycorrhizal fungi

320

Drought, floods and water quality: Drivers of a severe hypoxic blackwater event in a major river system (the southern Murray–Darling Basin, Australia)

321

Drought-adaptive mechanisms involved in the escape/tolerance strategies of Arabidopsis Landsberg erecta and Columbia ecotypes and their F1 reciprocal progeny

322

Drought-induced changes and recovery of photosynthesis in two bean cultivars (Phaseolus vulgaris L.)

323

Drought-induced changes in acid phosphatase activities in wheat in relationship with phosphorus

324

Drought-induced chilling tolerance in cucumber involves Drought-induced chilling tolerance in cucumber involves

325

Drought-induced reduction in uptake of recently photosynthesized carbon by springtails and mites in alpine grassland

326

Drought-induced reduction in uptake of recently photosynthesized carbon by springtails and mites in alpine grassland

327

Drought-induced responses of photosynthesis and antioxidant metabolism in higher plants Review Article

328

Drought-induced variations of water relations parameters in Olea europaea

329

Drought-induced weakening of growth–temperature associations in high-elevation Iberian pines

330

Drought-resistant physiological characteristics of four shrub species in arid valley of Minjiang River, China

331

Drought-responsive mechanisms in rice genotypes with contrasting drought tolerance during reproductive stage

332

Droughts and famines: The underlying factors and the causal links among agro-pastoral households in semi-arid Makueni district, Kenya

333

DROUGHTS AND THEIR IMPACT ON THE ALBANIAN TERRITORY

334

Droughts as random events in the Maya lowlands

335

Drought-sensitivity ranking of deciduous tree species based on thermal imaging of forest canopies

336

Drove roads: Keystone structures that promote ant diversity in Mediterranean forest landscapes

337

Drowned coralline algal dominated deposits off Lanai, Hawaii; carbonate accretion and vertical tectonics over the last 30 ka

338

Drowned shelf-edge deltas, barrier islands and related features along the outer continental shelf north of the head of De Soto Canyon, NE Gulf of Mexico

339

Drowning by numbers and itʹs

340

Drowning discontinuities and stratigraphic correlation in platform carbonates. The late Barremian–early Aptian record of southeast France

341

Drowning in information, but thirsty for knowledge

342

Drowning of a nearshore peat-forming environment, Atane Formation (Cretaceous) at Asuk, West Greenland: sedimentology, organic petrography and geochemistry

343

Drowning out the protection racket: partner manipulation or drought can strengthen ant–plant mutualism

344

Drowning out the protection racket: partner manipulation or drought can strengthen ant–plant mutualism

345

Drowning-out crystallisation of sodium sulphate using aqueous two-phase systems

346

Drowning-out crystallization of l-proline: Effect of anti-solvent composition and processing parameters on crystal size and shape

347

Drowsiness Analysis Using Common Spatial Pattern and Extreme Learning Machine Based on Electroencephalogram Signal

348

Drowsiness Detection – A Visual System for Driver Support

349

Drs. Landon and Kahn respond:

350

dRTP and dPTP a complementary nucleotide couple for the Sequence Saturation Mutagenesis (SeSaM) method

351

Drucker–Prager–Cap creep modelling of pebble beds in fusion blankets

352

Drudeʹs model calculation rule on electrical transport in Sb-doped SnO2 thin films, deposited via sol–gel Original Research Article

353

Druen complement component C3a and C5a promote choroidal neovacularization

354

Drug Use Evaluation of Three Widely Prescribed Antibiotics in a

355

Drug absorption and release properties of crosslinked hydrogels based on diepoxy-terminated poly(ethylene glycol)s and aliphatic polyamines — a study on the effect of the gel molecular structure

356

Drug abuse among nurses: A neglected challenge

357

Drug Abuse among University Students of Rafsanjan, Iran

358

Drug abuse and aggression between intimate partners: A meta-analytic review

359

Drug abuse and bipolar disorder: comorbidity or misdiagnosis?

360

Drug abuse in older US adults worries experts

361

Drug Abuse in Prishtina Region

362

Drug Abuse Pattern and High Risk Behaviors among Addicts in Shahroud County of Semnan Province, Northeast Iran in 2009

363

Drug Abuse Research Trend Investigation with Text Mining

364

Drug abuse toll uncovered in Kenya

365

Drug abuse, HIV/AIDS and stigmatisation in a Dai community in Yunnan, China

366

Drug abuse: A significant variable in schizophrenia research

367

Drug Action at the 5-HT(1A) Receptor in Vivo: Autoreceptor and Postsynaptic Receptor Occupancy Examined with PET and [carbon:yl-11C]WAY-100635

368

Drug Action of Ritodrine on the Sarcoplasmic-Reticulum Ca2+-ATPase from Skeletal Muscle

369

Drug actions in preeclampsia: Aspirin, but not magnesium chloride or dihydralazine, differentially inhibits cultured human trophoblast release of thromboxane and prostacyclin without affecting angiotensin II, endothelin-1, or leukotriene B4 secretion

370

DRUG ADDICTION AND HEPATITIS B AND C IN PAKISTAN

371

Drug addiction and HIV infection on rise in Tajikistan

372

Drug addiction and the economic rationalization of gun control

373

Drug addiction and the economic rationalization of gun control

374

Drug Addiction and Vitamin D Supplementation: How to Address a Health Concern in Methadone Treatment?

375

Drug addiction as drive satisfaction ("antidrive") dysfunction

376

Drug Addiction as Risk for Suicide Attempts

377

Drug addiction in Gaza and the illicit trafficking of tramadol

378

Drug addiction: the neurobiology of disrupted self-control

379

Drug administration to poultry

380

Drug adverse events and drop-out risk: A clinical case

381

Drug advertisements and prescribing

382

Drug advertisements and prescribing

383

Drug advertisements in less-developed countries

384

Drug advertisements in medical journals

385

Drug advertisements that go straight to the hippocampus

386

Drug advertising in medical journals

387

Drug advertising in medical journals

388

Drug advertising in medical journals

389

Drug advertising in medical journals

390

Drug advertising in medical journals

391

Drug advertising in medical journals

392

Drug affinity to immobilized target bio-polymers by high-performance liquid chromatography and capillary electrophoresis

393

Drug allergic reactions and distress vulnerability

394

Drug allergies among patients with borderline personality symptomatology

395

396

Drug allergy transmitted by passionate kissing

397

Drug and alcohol abuse: A clinical guide to diagnosis and treatment (4th ed.) : Marc A. Schuckit. New York: Plenum Press, 1995. 371 pp. (xviii), $34.50

398

Drug and Alcohol Education for Consumer Workers and Caregivers: A Pilot Project Assessing Attitudes Toward Persons With Mental Illness and Problematic Substance Use

399

Drug and alcohol use among drivers admitted to a Level-1 trauma center

400

Drug and Alcohol Use in Emergency Medicine Residency: An Impaired Residentʹs Perspective

401

Drug and alcohol use in Spain: consumption habits, attitudes and opinions

402

Drug and cell encapsulation: Alternative delivery options for the treatment of malignant brain tumors

403

Drug and chemical metabolites in clinical toxicology investigations: The importance of ethylene glycol, methanol and cannabinoid metabolite analyses

404

Drug and DNA delivery to mitochondria

405

Drug and DNA delivery to mitochondria

406

Drug and ECT treatment of depression in the elderly, 1996–2001: a literature review

407

Drug and gene delivery to mucosal tissues: the mucus barrier

408

Drug and herbal medicine-induced nephrotoxicity in children; review of the mechanisms

409

Drug Attitude Inventory in Patients with Bipolar Disorder: Psychometric Properties

410

Drug biotransformation by human hepatocytes. In vitro/in vivo metabolism by cells from the same donor

411

DRUG BIT CUTTING TRACE IMAGE COLOURS AND CUTTING FORCE FLUCTUATION RELATION

412

Drug bulletins: independent information for global use

413

Drug Calculation Cards and Medication Errors in the Neonatal Intensive Care Units

414

Drug calculation skills — Are we running scared?

415

Drug Calculations for Nurses: Robert Lapham, Heather Agar, Arnold, 1995, 0-340604-79-4, 250 pages, Price £5.99

416

Drug choices in the treatment of atrial fibrillation

417

Drug classification systems: Applications and characteristics

418

Drug Clearance and Arterial Uptake After Local Perivascular Delivery to the Rat Carotid Artery

419

Drug combinations best in acute asthma attacks

420

Drug combinations for HD tested in Drosophila

421

Drug combinations for malaria: time to ACT?

422

Drug combinations in pain treatment: a review of the published evidence and a method for finding the optimal combination

423

Drug companies can broadcast across Europe

424

Drug companies caught again for fixing worldwide vitamin prices

425

Drug company sued over research trial in Nigeria

426

Drug company trials come under increasing scrutiny

427

Drug comparison and categorizing regarded with human serum albumin

428

Drug complications poorly recorded in medical charts

429

Drug courts for DWI offenders? The effectiveness of two hybrid drug courts on DWI offenders

430

Drug courts: A bridge between criminal justice and health services

431

Drug Craving Terminology among Opiate Dependents;

432

Drug Cravings and Its Relationship With Family Communication Patterns and Resiliency Through the Mediatory Role of Difficulty in Cognitive Emotion Regulation

433

Drug crops threaten Colombian birds

434

435

Drug delivery and tissue engineering applications of biocompatible pectin–chitin/nano CaCO3 composite scaffolds

436

Drug delivery applications of supercritical fluid technology

437

Drug delivery design for intravenous route with integrated physicochemistry, pharmacokinetics and pharmacodynamics: Illustration with the case of taxane therapeutics

438

Drug delivery devices based on macroporous silica spheres

439

Drug Delivery for Brains and Central Nervous System

440

Drug delivery for in vitro fertilization: Rationale, current strategies and challenges

441

Drug delivery from gold and titanium surfaces using self-assembled monolayers

442

Drug delivery from hydrophobic-modified mesoporous silicas: Control via modification level and site-selective modification

443

Drug delivery in degenerative joint disease

444

Drug delivery in degenerative joint disease: Where we are and where to go?

445

Drug delivery investigations of quaternised poly(propylene imine) dendrimer using nimesulide as a model drug

446

Drug Delivery of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) to Target Brain Tumors

447

Drug Delivery Platforms for Vaginal Infection: Biological Barriers, Microbe-Associated Infections, and Delivery

448

Drug delivery property, bactericidal property and cytocompatibility of magnetic mesoporous bioactive glass

449

Drug delivery strategies for photodynamic antimicrobial chemotherapy: From benchtop to clinical practice

450

Drug delivery strategies in the therapy of inflammatory bowel disease

451

Drug delivery strategies to treat age-related macular degeneration

452

Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities

453

Drug delivery system based on cyclodextrin-naproxen inclusion complex incorporated in electrospun polycaprolactone nanofibers

454

Drug delivery systems : Vascant V. Ranade and Mannfred A. Hollinger CRC Press, Boca Raton, Florida, 1995, 364 pp. Dr Lisa Brannon-Peppas

455

Drug delivery systems using sandwich configurations of electrospun poly(lactic acid) nanofiber membranes and ibuprofen

456

Drug delivery systems: polymers and drugs monitored by capillary electromigration methods

457

Drug delivery therapies I: General trends and its importance on bone tissue engineering applications

458

Drug delivery therapies II.: Strategies for delivering bone regenerating factors

459

Drug Delivery through Nose: A Noninvasive Technique for Brain Targeting

460

Drug delivery to mitochondria: the key to mitochondrial medicine

461

Drug delivery to mitochondria: the key to mitochondrial medicine

462

Drug delivery to peroxisomes: Employing unique trafficking mechanisms to target protein therapeutics

463

Drug delivery to solid tumors by elastin-like polypeptides

464

Drug delivery to the brain in Alzheimerʹs disease: Consideration of the blood–brain barrier

465

Drug delivery to the brain-just a sniff away

466

Drug delivery to the central nervous system by polymeric nanoparticles: What do we know?

467

Drug delivery to the posterior segments of the eye

468

Drug delivery vehicles on a nano-engineering perspective

469

Drug Demand Function for Iranian Urban Households Based on Householdsʹ Budget

470

Drug Dependency and Womenʹs Health

471

Drug dependent parents: Childcare responsibilities, involvement with treatment services, and treatment outcomes

472

Drug deregulation in Japan likely by 1998

473

Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase

474

Drug design and synthesis of ε opioid receptor agonist: 17-(cyclopropylmethyl)-4,5α-epoxy-3,6β-dihydroxy-6,14-endoethenomorphinan-7α-(N-methyl-N-phenethyl)carboxamide (TAN-821) inducing antinociception mediated by putative ε opioid receptor Original Resea

475

Drug design with a new transition state analog of the hydrated carbonyl: silicon-based inhibitors of the HIV protease Original Research Article

476

Drug design, synthesis, and evaluation of a non-sugar-based selectin antagonist

477

Drug design; HIV; Organosilane; Protease inhibitor; Silanediol

478

Drug detection based on the conformational changes of calmodulin and the fluorescence of its enhanced green fluorescent protein fusion partner Original Research Article

479

Drug detection by tandem mass spectrometry on the basis of adduct formation

480

Drug development and clinical research in the UK

481

Drug development for neglected diseases

482

Drug development for neglected diseases: a deficient market and a public-health policy failure

483

Drug development for tuberculosis: the missing ingredient

484

Drug development output: what proportion for tropical diseases?

485

Drug diffusion from disperse systems with a hydrophobically modified polysaccharide: Enhancer® vs Franz cells

486

Drug diffusion in hydrophobically modified N,N-dimethylacrylamide hydrogels

487

Drug Diffusion Inside a Non-Degradable Hydrogel Microneedle

488

DRUG DISCONTINUATION IN EPILEPTIC CHILDREN: PREDICTIVE VALUE OF THE EEG

489

Drug Discovery Acceleration Using Digital Microfluidic Biochip Architecture and Computer-aided-design Flow

490

Drug discovery and chemokine receptor antagonists: eppur si muove!

491

Drug Discovery and Delivery in the 21st Century

492

Drug Discovery and Evaluation

493

Drug discovery and sea hares: bigger is better

494

Drug Discovery in the Clouds

495

Drug discovery in the new millennium: the pivotal role of biotechnology

496

Drug discovery in the wake of genomics

497

Drug discovery of the future: the implications of the human genome project

498

Drug discovery through stem cell-based organoid models

499

Drug dispensing systems in Gaza hospitals: a comparative study

500

Drug disposition in obesity and protein-energy malnutrition

501

Drug distribution within poly(ɛ-caprolactone) microspheres and in vitro release

502

Drug dosing errors in simulated paediatric emergencies – Comprehensive dosing guides outperform length-based tapes with precalculated drug doses

503

Drug efficacy of praziquantel and albendazole in school children in Mwea Division, Central Province, Kenya

504

Drug efflux transporters in the CNS

505

Drug elimination in chronic liver diseases

506

Drug eluting stent

507

Drug ELuting Stent Complications

508

Drug eluting stent implantation for the treatment of symptomatic myocardial bridging is associated with favorable peri-procedural results and short-term outcomes

509

Drug Eluting Stent Restenosis

510

Drug eluting stents

511

Drug Eluting Stents Comparisons

512

Drug Eluting Stents I

513

Drug Eluting Stents II

514

Drug Eluting Stents in Diabetic Patients

515

Drug eluting stents may not be the answer for myocardial bridges

516

Drug eluting stents: Comparative results

517

Drug eluting stents: Current status and new developments

518

Drug eluting stents: In stent restenosis

519

Drug eluting stents: Long term results

520

Drug eradicates Chagasʹ parasite in mice

521

Drug evaluations using a novel microphysiometer based on cell-based biosensors

522

Drug excretion in breast milk: mechanisms, models and drug delivery implications for the infant

523

Drug excretion into breast milk—Overview

524

Drug exposed infants in the social welfare system and Juvenile Court

525

Drug firm buys up chain of US cancer clinics

526

Drug firm compensates patients for suspected hepatitis B vaccine failure

527

Drug firm support of American Medical Association ethics effort draws fire

528

Drug firm withdraws statin from the market

529

Drug firms lose patent rights lawsuit against South Africaʹs government

530

Drug firmsʹ representatives express concern over WHOʹs AIDS drug list

531

Drug firms take South Africaʹs government to court

532

Drug firms under fire over anti-competition in USA

533

Drug for impotence breaks prescription records

534

Drug Guru: A computer software program for drug design using medicinal chemistry rules Original Research Article

535

Drug Hypersensitivity Reactions in Hospital-Admitted Children: A Single Center Study in Southern Iran

536

drug hypersensitivity reactions in hospital-admitted children: a single center study in southern iran

537

Drug identification performance on the basis of observable signs and symptoms

538

Drug immunosuppression therapy for adult heart transplantation. Part 1: immune response to allograft and mechanism of action of immunosuppressants

539

Drug immunosuppression therapy for adult heart transplantation. Part 2: clinical applications and results

540

Drug impurity profiling: Method optimization on dissimilar chromatographic systems: Part I: pH optimization of the aqueous phase Original Research Article

541

DRUG INDUCED (CALCIUM CHANNEL BLOCKERS) GINGIVAL HYPERPLASIA

542

Drug Induced Autoimmune Hepatitis by Amoxicillin- Clavulanate

543

Drug induced blistering and the plastic surgeon: a case of amitriptyline induced skin necrosis

544

Drug Induced Ectropion: a Systematic Review

545

Drug Induced Gingival Overgrowth and Its Management

546

Drug induced hepatitis among Iranian patients suffering from tuberculosis

547

Drug Induced Sialorrhea and Microfluidic-Chip-Electrophoretic Analysis of Engorged Adult Female Tick Saliva of Haemaphysalis longicornis (Acari: Ixodidae)

548

Drug Induced Sleep Endoscopy in Obstructive Sleep Apnea

549

Drug industry lobbies against European research-data directive

550

Drug Information Resources at Private Community Pharmacies in Kuwait

551

Drug Injecting and HIV Infection: Global Dimensions and Local Responses; Edited by Gerry Stimson, Don C. Des Jarlais and Andrew Ball. UCL Press Ltd, London, 1998. 294 pp, £14.95 (paper).

552

Drug injection and associated factors among the elderly living with HIV/AIDS in Tehran, Iran

553

Drug injection cessation among HIV-infected injecting drug users

554

Drug interaction between rifampicin and sirolimus in transplant patients

555

Drug Interaction of Glycyrrhiza glabra L. with Chemical Drugs: A mini Review study

556

Drug interaction of St Johnʹs wort with ciclosporin

557

Drug Interactions Among Hospitalized Patients in Intensive Care Units and Infectious Ward, Hamadan, Iran

558

Drug interactions and anti-infective therapies

559

Drug Interactions between Psychoactive Agents and Antiepileptic Agents

560

Drug Interactions Casebook: The Cytochrome P450 System and Beyond, 2nd ed.: By Neil B. Sandson. Washington, DC, American Psychiatric Press, 2003 ($35.50, paperback ed.), 334 pp

561

Drug interactions in cancer patients: A hidden risk?

562

Drug Interactions in Iranian Veterans With Chronic Spinal Cord Injury - A Descriptive Study

563

Drug Interactions of Green Tea

564

Drug Interactions of Medicinal Plants with Chemical Antidiabetic Drugs

565

Drug Interactions of Metformin Involving Drug Transporter Proteins

566

Drug Interactions of Psychiatric and COVID-19 Medications

567

Drug interactions of zonisamide with phenytoin and sodium valproate: serum concentrations and protein binding

568

Drug interactions with potential rubber closure extractables: Identification of thiol–disulfide exchange reaction products of captopril and thiurams

569

Drug interactions with the taxanes: clinical implications

570

Drug interactions with zileuton

571

Drug interactions with zileuton

572

Drug interactions—fact or fiction?

573

Drug intervention trials in sepsis

574

Drug intervention trials in sepsis: divergent results

575

Drug kinetics and drug resistance in optimal chemotherapy

576

Drug Literacy in Iran: the Experience of Using “The Single Item Health Literacy Screening (SILS) Tool”

577

Drug loaded poly[Lac(Glc-Leu)] microparticles: Formulation and release characteristics

578

Drug loaded thermoresponsive and cytocompatible chitosan based hydrogel as a potential wound dressing

579

Drug loading onto ion-exchange microspheres: Modeling study and experimental verification

580

Drug loading, dispersion stability, and therapeutic efficacy in targeted drug delivery with carbon nanotubes Original Research Article

581

Drug Management in Crisis and Disaster in Selected Countries and Iran

582

DRUG MANAGEMENT REVIEWS IN DISTRICT DRUG MANAGEMENT UNIT AND GENERAL HOSPITAL

583

Drug may avoid need for parathyroidectomy

584

Drug Mediated S-glutathionylation of PDI leads to alterations in secondary structure, inhibition of isomerase activity, and triggers ER-stress induced apoptosis

585

Drug metabolism and drug interactions in the elderly

586

Drug metabolism enzymes in a steatotic model of rat treated with a high fat diet and a low dose of streptozotocin

587

Drug name confusion: evaluating the effectiveness of capital (“Tall Man”) letters using eye movement data

588

Drug nanocarrier agents based on starch-g-amino acids

589

Drug Nano-Particles Formation by Supercritical Rapid Expansion Method; Operational Condition Effects Investigation

590

Drug partition chromatography on immobilized porcine intestinal brush border membranes

591

Drug Patents 2001: A Review of Pharmaceutical Patenting, 1995–2001

592

Drug permeation modeling through the thermo-sensitive membranes of poly(N-isopropylacrylamide) brushes grafted onto micro-porous films

593

Drug permeation through temperature-sensitive membranes prepared from poly(vinylidene fluoride) with grafted poly(N-isopropylacrylamide) chains

594

Drug policy in China: pharmaceutical distribution in rural areas

595

Drug policy: should the law take a back seat?

596

Drug prescribing practices of general practitioners and paediatricians for childhood diarrhoea in Karachi, Pakistan

597

Drug prescription habits in public and private health facilities in 2 provinces in South Africa

598

Drug Prescription Pattern in a Nigerian Tertiary Hospital

599

Drug prescriptions after acute myocardial infarction: Dosage, compliance, and persistence

600

Drug prescriptions and referral to cardiac rehabilitation after acute coronary events: comparison between men and women in the French PREVENIR Survey

601

Drug prevents SIV infection

602

Drug pricing policies in one of the largest drug manufacturing nations in the world: Are affordability and access a cause for concern?( Editorial Jan-Mar 2015 / Vol 4 / Issue 1)

603

Drug problem recognition among african american drug-using arrestees

604

Drug Properties, Chemical Reactivity and Docking Binding Energy of Cinnamon with Estrogen, Testosterone, Progesterone as Potential Drug: Theoretical Investigation

605

Drug quality, a contributor to drug resistance?

606

Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) Cause Interstitial Nephritis: a case Report and Review of Literatures

607

Drug Rash With Eosinophilia and Systemic Symptoms Syndrome in Infancy: A Report of Two Rare Cases

608

Drug rash with eosinophilia and systemic symptoms vs toxic epidermal necrolysis: the dilemma of classification

609

Drug Reaction with Eosinophilia and Systemic Symptom in a Patient with Pneumonia and Hyperthyroidism

610

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Presenting with Primary Diagnosis of Hepatocellular Carcinoma

611

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome and Myocarditis: A Case Report and Literature Review on Fatal Complications of Reactivated Viral Infections

612

Drug Reaction With Eosinophilia and Systemic Symptoms Induced by Valproic Acid: A Case Report

613

Drug Reaction With Eosinophilia and Systemic Symptoms Induced by Valproic Acid: A Case Report

614

Drug reaction with eosinophilia and systemic symptoms syndrome associated with Nitrofurantoin

615

Drug Receptor Identification from Multiple Tissues Using Cellular-Derived mRNA Display Libraries Original Research Article

616

Drug Recognition and Stabilisation of the Parallel-stranded DNA Quadruplex d(TTAGGGT)4 Containing the Human Telomeric Repeat

617

Drug referendum backs Swiss government

618

Drug reimportation: sitting in the middle

619

Drug related deaths in Tehran, Iran: Toxicological, Death and Crime Scene investigations

620

Drug related deaths—causes and numbers

621

Drug Related Hospital Admissions; A Systematic Review of the Recent Literatures

622

Drug release behavior of beads and microgranules of chitosan

623

Drug release behavior of chitosan–montmorillonite nanocomposite hydrogels following electrostimulation

624

Drug Release Characteristics and Tissue Distribution of Rifapentine Polylactic Acid Sustained-Release Microspheres in Rabbits after Paravertebral Implantation

625

Drug release characteristics of phase separation pHEMA sponge materials

626

Drug release from a N-vinylpyrrolidinone/acrylic acid lubricious hydrophilic coating

627

Drug release from a porous ion-exchange membrane in vitro

628

Drug release from a two-layer stent coating considering the viscoelastic property of the arterial wall: A mathematical and numerical study

629

Drug release from calcium and zinc pectinate beads: Impact of dissolution medium composition

630

Drug release from chitosan–alginate complex beads reinforced by a naturally occurring cross-linking agent

631

Drug release from ion-exchange microspheres: Mathematical modeling and experimental verification

632

Drug release from layered double hydroxides and from their polylactic acid (PLA) nanocomposites

633

Drug release from starch-acetate microparticles and films with and without incorporated α-amylase

634

Drug release from α,β-poly(N-2-hydroxyethyl)- -aspartamide-based microparticles

635

Drug release kinetics and biological properties of a novel local drugcarrier system

636

Drug release kinetics from monolayer films of glucose-sensitive microgel

637

Drug release mechanisms of chemically cross-linked albumin microparticles: Effect of the matrix erosion

638

Drug release rate and kinetic investigation of composite polymeric nanofibers

639

Drug Release Studies from Caesalpinia pulcherrima Seed Polysaccharide

640

Drug Release Studies of Naproxen Agglomerates Produced by the Antisolvent Approach in the Presence of Hydroxypropyl Cellulose

641

Drug release through liposome pores

642

Drug Repositioning and Pharmacophore Identification in the Discovery of Hookworm MIF Inhibitors Original Research Article

643

Drug Repositioning: A Review

644

Drug Repurposing for Identification of S1P1 Agonists with Potential Application in Multiple Sclerosis Using In Silico Drug Design Approaches

645

Drug Repurposing Is a New Opportunity for Developing Drugsagainst Neuropsychiatric Disorders

646

Drug resistance against 5-fluorouracil and cisplatin in the treatment of head and neck squamous cell carcinoma: A systematic review

647

Drug resistance among acid-fast bacilli

648

Drug resistance among chronic HIV-1-infected patients naïve for use of anti-retroviral therapy in Sao Paulo city

649

Drug resistance and apoptosis-inducing strategies in cancer therapy

650

Drug resistance and influenza pandemics

651

Drug resistance and influenza pandemics

652

Drug resistance and influenza pandemics

653

Drug resistance and influenza pandemics

654

Drug Resistance and Serotyping of Uropathogenic Escherichia coli Among Patients With Urinary Tract Infection in Rasht, Iran

655

Drug resistance and Susceptibility of Mycobacterium tuberculosis identified at University Kebangsaan Malaysia Medical Centre

656

Drug Resistance and the Prevention Strategies in Food Borne Bacteria: An Update Review

657

Drug resistance and virulence-associated genes screening in Salmonella enterica isolated from Caspian pony, Iran

658

Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors

659

Drug resistance gene transfer: Stem cell protection and therapeutic efficacy

660

Drug resistance in cancer, J.H. Goldie, A.J. Goldman. Cambridge University Press, Cambridge (1998)

661

Drug resistance in epilepsy: not futile, but complex?

662

Drug Resistance in Equine Parasites: An Emerging Global Problem

663

Drug resistance in isolated bacteria from milk of sbeep and goats witb subclinical mastitis in Sbabrekord district

664

Drug resistance in malaria: Its population biology and implications for control

665

Drug Resistance in the Clinical Management of HIV – A Special Focus on the Adherence Issues

666

Drug resistance in tuberculosis—a reinfection model

667

Drug resistance models for malaria

668

Drug Resistance of Acinetobacter in Selected Hospitals

669

Drug resistance of isolated strains of Pseudomonas Aeruginosa from burn wound infections to selected antibiotics and disinfectants

670

DRUG RESISTANCE OF MYCOBACTERIUM TUBERCULOSIS

671

Drug Resistance of Mycobacterium tuberculosis Complex among Newly Diagnosed Tuberculosis Cases in Burkina Faso

672

Drug Resistance of Pseudomonas aeruginosa and Enterobacter cloacae Isolated from ICU, Babol, Northern Iran

673

DRUG RESISTANCE PATTERN AMONG AFB SMEAR POSITIVE RETREATMENT COMPLETED CASES

674

Drug resistance pattern and associated risk factors of tuberculosis patients in the central province of Iran

675

Drug resistance pattern and outcome of treatment in recurrent episodes of tuberculosis

676

Drug Resistance Pattern of Pseudomonas aeruginosa Isolates Carrying MexAB-OprM Efflux Pump’s Associated Genes in Companion Birds with Respiratory Infection

677

Drug resistance pattern of Pseudomonas aeruginosa strains isolated from cystic fibrosis patients at Isfahan AL Zahra hospital, Iran (2009-2010)

678

Drug Resistance Patterns in HIV Patients with Virologic Failure in Iran

679

Drug resistance patterns in pulmonary tuberculosis

680

Drug resistance profile and subtyping of HIV-1 RT gene in Iranian patients under treatment

681

Drug resistance reversal activity of anticancer drug loaded solid lipid nanoparticles in multi-drug resistant cancer cells

682

Drug Resistance versus Spiritual Resistance: A Comparative Analysis from the Perspective of Spiritual Health

683

Drug resistance, plasmids, biotypes and susceptibility to bacteriophages of Salmonella isolated from poultry in Canada

684

Drug Resistance: A Periplasmic Ménage à Trois

685

Drug resistance–virulence relationship in Plasmodium falciparum causing severe malaria in an area of seasonal and unstable transmission

686

Drug resistant neuroleptic malignant syndrome and the role of electroconvulsive therapy

687

Drug resistant Plasmodium falciparum in an area of seasonal transmission

688

Drug resistant tuberculosis in Africa: Current status, gaps and opportunities

689

Drug Resistant Tuberculosis: Gold, Glitter and Hope

690

Drug risk assessment with determining the number of sub-populations under finite mixture normal models

691

Drug Safety Crises Management in Pharmacovigilance

692

Drug Screening versus History in detection of substance use in ED Psychiatric Patients

693

694

Drug sensitivity of trypanosome populations from cattle in a peri-urban dairy production system in Uganda

695

Drug sensitivity patterns of bacterial isolates from septic post-operative wounds in a regional referral hospital in Uganda

696

Drug shows potential for treatment of Huntingtonʹs disease

697

Drug shows promise for treatment of Alzheimerʹs disease

698

Drug solubility: how to measure it, how to improve it

699

Drug Stroop performance: Relationships with primary substance of use and treatment outcome in a drug-dependent outpatient sample

700

Drug subsidy could help Tanzania tackle malaria

701

Drug Supply Chain Management and Implementation of Health Reform Plan in Teaching Hospital Pharmacies of Ahvaz, Iran

702

DRUG SUSCEPTIBILITY OF STREPTOCOCCUS PNEUMONIAE STRAINS ISOLATED IN TEHRAN, IRAN

703

Drug Switching, a Creative Approach to Leukemia Therapy

704

Drug target inference through pathway analysis of genomics data

705

Drug targeting of airway surface liquid: A pharmacological MRI approach

706

Drug targeting to choroidal neovascularization

707

Drug targeting to hypoxic tissue using self-inactivating bioreductive delivery systems

708

Drug targeting to the kidney

709

Drug targeting to the kidney: Advances in the active targeting of therapeutics to proximal tubular cells

710

Drug testing litigation: Trends and outcomes

711

Drug testing sworn law enforcement officers: One agencyʹs experience

712

Drug Therapeutic Failures as a Cause of Admission to an Intensive Care Unit at a University Hospital

713

714

715

Drug therapy and microvolt T-wave alternans testing

716

Drug therapy and microvolt T-wave alternans testing

717

Drug therapy for chronic hepatitis B: antiviral efficacy and influence of hepatitis B virus polymerase mutations on the outcome of therapy

718

Drug therapy for coronary heart disease: the Sheffield table

719

Drug therapy for coronary heart disease: the Sheffield table

720

Drug therapy for coronary heart disease: the Sheffield table

721

Drug therapy for coronary heart disease: the Sheffield table

722

Drug therapy for coronary heart disease: the Sheffield table

723

Drug therapy for coronary heart disease: the Sheffield table

724

Drug Therapy for Hypercholesterolemia in Patients With Cardiovascular Disease: Factors Limiting Achievement of Lipid Goals

725

Drug Therapy for Hypercholesterolemia: Time to End the Double Standard

726

Drug therapy for inflammatory bowel disease in pregnancy and the puerperium

727

Drug therapy for management of obesity

728

Drug therapy for management of obesity

729

Drug Therapy for Small Abdominal Aortic Aneurysm

730

Drug therapy for treatment of obesity

731

Drug therapy for urinary incontinence

732

Drug therapy for vertebral fractures in osteoporosis: Evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy

733

Drug Therapy in Atrial Fibrillation Management: Where Do We Stand in 2010?

734

Drug therapy in paediatric patients

735

Drug therapy in reproductive endocrinology

736

Drug therapy increases long-term survival in pulmonary hypertension patients

737

Drug therapy of diabetes in the elderly

738

Drug therapy versus implantation of a cardiac defibrillator for the treatment of malignant arrhythmias in left ventricular dysfunction

739

Drug Tolerance in Replicating Mycobacteria Mediated by a Macrophage-Induced Efflux Mechanism

740

Drug Trafficking and Criminal Justice

741

Drug trajectories among youth undergoing treatment: The influence of psychological problems and delinquency

742

Drug transfer through mucus

743

Drug transfer through mucus

744

Drug transport in corneal epithelium and blood–retina barrier: Emerging role of transporters in ocular pharmacokinetics

745

Drug Transport Mechanism of Oral Antidiabetic Nanomedicines

746

Drug transport mechanisms and release kinetics from molecularly designed poly(acrylic acid-g-ethylene glycol) hydrogels

747

Drug transport proteins in the liver

748

Drug treatment behind bars: Prison-based strategies for change : By Kevin E. Early Praeger Publishers (P.O. Box 5007, Westport, Connecticut 06881-5007), 1996, 192 pp., hardcover—$55.00

749

Drug treatment for bleeding oesophageal varices

750

Drug treatment for Crohnʹs disease

751

Drug treatment of bothersome lower urinary tract symptoms after ureteric JJ-stent insertion: A contemporary, comparative, prospective, randomised placebo-controlled study, single-centre experience

752

Drug treatment of delirium: Past, present and future

753

Drug treatment of non-variceal upper gastrointestinal bleeding

754

Drug treatment of obesity

755

Drug Treatment of Patients with Liver Cirrhosis in a Tertiary Hospital in Northern Ghana: Does It Comply with Recommended Guidelines?

756

Drug treatment outcome methodology (1993–1997): Strengths, weaknesses, and a comparison to the alcohol field

757

Drug treatment-related factors of inadequate seizure control

758

Drug treatments for obesity

759

Drug treatments for obesity

760

Drug treatments for obesity

761

Drug treatments for obesity – Authorsʹ reply

762

Drug treatments for obesity: orlistat, sibutramine, and rimonabant

763

Drug treatments of levodopa-induced dyskinesias

764

Drug Use among Residents of Juvenile Correctional Center in Kerman, Iran, and its Relationship with Personality Dimensions and Self-concept

765

Drug use and abuse in sport

766

Drug use and drinking among students in 36 countries

767

Drug Use and High-Risk Sexual Behaviors of Women at a Drop-In Center in Mazandaran Province, Iran, 2014

768

Drug use and HIV/ AIDS in Burma

769

Drug Use and Sex Work Among At-risk Women: A Qualitative Study of Initial Factors

770

Drug use and the severity of a traffic accident

771

Drug use behaviors among asian drug users in san francisco

772

Drug use behaviour of pregnant women in rural India

773

Drug use during pregnancy

774

Drug use during pregnancy

775

Drug use during pregnancy: are risk classifications more dangerous than the drugs?

776

Drug use evaluation of antibiotics prescribed in a Jordanian Hospital outpatient and emergency clinics using WHO prescribing indicators

777

Drug use evaluation of antibiotics prescribed in a Jordanian hospital outpatient and emergency clinics using WHO prescribing indicators

778

Drug Use Evaluation of Crystalline Penicillin in Pediatrics Ward of Dessie Referral Hospital, North East Ethiopia: A Hospital Based Cross Sectional Study

779

Drug Use Evaluation of Human Intravenous Immunoglobulin (IVIG) in a Teaching Hospital in East of Iran

780

Drug Use for Secondary Prevention of Cardiovascular Diseases in Golestan, Iran: Results From the Golestan Cohort Study

781

Drug use is associated with elevated food consumption in college students

782

Drug Use Pattern Among Elderly People Referred to the Retirement Centers

783

Drug Use Patterns at Major Rock Concert Events

784

Drug usersʹ access to community-based services

785

Drug usersʹ brains to be removed 2 hours after death

786

Drug usersʹ sexual relationships and the social organisation of risk: The sexual relationship as a site of risk management

787

Drug utilisation and self-medication in rural communities in Vietnam

788

Drug utilization and nutrition patterns among children from indigent and emigrant families in Crete, Greece

789

Drug Utilization Evaluation of Agents Administered for Prevention and Treatment of Cancer-Related Infections

790

Drug Utilization Evaluation of Antibiotics in Burn Patients at a Referral Teaching Hospital

791

Drug Utilization Evaluation of Antibiotics in Intensive Care Units of a Referral Teaching Hospital

792

Drug Utilization Evaluation of Carbapenems in a Teaching Hospital in Tabriz-Iran

793

Drug Utilization Evaluation of Carbapenems in a Teaching Hospital in Tabriz-Iran

794

Drug Utilization Evaluation of Cefepime and Meropenem Based on the Infectious Disease Society of America and Defined Daily Dose Guidelines at the Payambare-Azam Bandar Abbas Hospital: A Retrospective Study

795

Drug Utilization Evaluation of Colistin: A Retrospective Study

796

Drug Utilization Evaluation of Imipenem and Intravenous Ciprofloxacin in a Teaching Hospital

797

Drug Utilization Evaluation of Imipenem in an Educational Hospital in Mazandaran Province

798

Drug Utilization Evaluation of Imipenem in Patients Undergoing Bone Marrow Transplantation

799

Drug utilization evaluation of meropenem: an important broad-spectrum antibiotic for the treatment of serious bacterial infections in hospitalized patients

800

Drug utilization evaluation of Rivaroxaban in both inpatient and outpatient settings: Using standard guidelines

801

Drug utilization evaluation of third generation cephalosporins using core drug use indicators

802

Drug Utilization Evaluation of Two Broad-Spectrum Antimicrobials: Cefepime and Piperacillin/Tazobactam in a Teaching Hospital in Tabriz, Iran

803

Drug Utilization Evaluation of Vancomycin in a Referral Infectious Center in Mazandaran Province

804

Drug Utilization Evaluation of Vancomycin in Pediatric Department

805

Drug utilization patterns in Rawalpindi and Islamabad, Pakistan

806

Drug Utilization Review of Conventional Amphotericin B in Febrile Neutropenic Patients Hospitalized at a Bone Marrow Transplant Center

807

Drug Utilization Review of Vancomycin in Febrile Neutropenic Patients Hospitalized at a Bone Marrow Transplantation Center

808

Drug Utilization Study on Acute Poisoning Cases Treated at a Tertiary Care Hospital in Western Part of India

809

Drug with potential to clear amyloid

810

Drug/device combinations for local drug therapies and infection prophylaxis

811

Drug-Coated Balloons for Infrapopliteal Disease: Digging Deep to Understand the Impact of a Negative Trial

812

Drug-company sponsorship and the Declaration of Helsinki

813

Drug-company sponsorship and the Declaration of Helsinki

814

Drug-delivering coronary artery stents: bare metal threatened by extinction?

815

Drug-Dependent Requirement of Hippocampal Neurogenesis in a Model of Depression and of Antidepressant Reversal

816

Drug–DNA interaction: A theoretical study on the binding of thionine with DNAs of varying base composition

817

Drug–DNA interactions and their study by UV–Visible, fluorescence spectroscopies and cyclic voltametry

818

Drug-drug and drug-disease interactions in the ED: Analysis of a high-risk population

819

Drug-drug co-crystals

820

Drug-Drug Interaction Extraction via Convolutional Neural Networks

821

Drug–drug interaction mediated by inhibition and induction of P-glycoprotein

822

Drug-Drug Interactions among Kidney Transplant Recipients in The Outpatient Setting

823

Drug‐Drug Interactions in Elderly Adults in Dentistry Care: a Cross-Sectional Study

824

Drug-drug interactions in inpatient and outpatient settings in Iran: a systematic review of the literature

825

Drug-Drug Interactions: Influence of verapamil on the pharmacokinetics of sitagliptin in rats and Ex vivo models

826

Drug‑drug Interactions: The Importance of Medication Reconciliation (Letters to the Editor Volume 6 - Issue 1 - January-March 2017 )

827

Drug-drug interation prediction between ketoconazole and anti-liver cancer drug Gomisin G

828

Drug-Drug/Drug-Excipient Compatibility Studies on Curcumin using Non-Thermal Methods

829

Drug-Drug-Induced Akathisia: Two Case Reports

830

Drug-efficacy depends on the inhibitor type and the target position in a metabolic network—A systematic study

831

Drug-eluted stent fracture occurred within 3 years lead to chronic total occlusion and aneurysm

832

Drug-eluting Balloon (DEB) for De-Novo Coronary Artery Disease and In-stent Restenosis: Immediate and Intermediate Term Results from a Prospective Registry

833

Drug-Eluting Balloon for Treatment of Superficial Femoral Artery In-Stent Restenosis

834

Drug-Eluting Balloon Versus Standard Balloon Angioplasty for Infrapopliteal Arterial Revascularization in Critical Limb Ischemia: 12-Month Results From the IN.PACT DEEP Randomized Trial

835

Drug-eluting bioabsorbable stents – An in vitro study

836

Drug-Eluting Compared With Bare-Metal Coronary Stents Among Elderly Patients Original Research Article

837

Drug-eluting stent fracture occurred within 2 days after stent implantation

838

Drug-Eluting Stent Fracture within 6 Days after Stent Implantation

839

Drug-Eluting Stent Fracture: Promise and Performance

840

Drug-Eluting Stent Implantation and Coronary Collateral Growth Attenuation: Is Drug the Only Culprit?

841

Drug-Eluting Stent Implantation May Not Affect Vasomotor Function in Early Phase

842

Drug-Eluting Stent Restenosis: The Pattern Predicts the Outcome Original Research Article

843

Drug-Eluting Stent Thrombosis: A Pooled Analysis

844

Drug-Eluting Stent Thrombosis: A Pooled Analysis: Reply

845

Drug-Eluting Stent Thrombosis: Increasingly Recognized But Too Frequently Overemphasized

846

Drug-eluting stent thrombosis: Results from a pooled analysis including 10 randomized studies Original Research Article

847

Drug-Eluting Stent Thrombosis: Results From the Multicenter Spanish Registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos) Original Research Article

848

Drug-Eluting Stent-Induced Left Anterior Descending Coronary Artery Aneurysm: Repair by Pericardial Patch—Where Are We Headed?

849

Drug-Eluting Stent-Induced Vascular Dysfunction: Common and Missing Links

850

Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients With Diabetes Mellitus: The DECLARE-DIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy With Dual Antiplatelet Therapy After Drug-Eluting Stent I

851

Drug-Eluting Stenting for Unprotected Left Main Coronary Artery Disease: Are We Ready to Replace Bypass Surgery?

852

Drug-Eluting stents

853

Drug-Eluting Stents “Next Generation” Basic Science Workshop

854

Drug-eluting stents 1— preclinical

855

Drug-eluting stents 2-economics and cost effectiveness

856

Drug-eluting stents 3-restenosis following stenting with drug-eluting stents

857

Drug-eluting stents 4-paclitaxel, everolimus, and other agents

858

Drug-eluting stents and glycoprotein IIb/IIIa inhibitors: Combination therapy for the future

859

Drug-Eluting Stents and Late Adverse Clinical Outcomes: Lessons Learned, Lessons Awaited

860

Drug-eluting stents and late stent thrombosis

861

Drug-Eluting Stents and the Future of Coronary Artery Bypass Surgery: Facts and Fiction

862

Drug-Eluting Stents Are Safe and Effective: Right or Wrong?

863

Drug-Eluting Stents for Acute Myocardial Infarction

864

Drug-eluting stents for coronary artery disease: A review

865

Drug-Eluting Stents for Critical Limb Ischemia

866

Drug-eluting stents for diabetes mellitus: A rush to judgment? Review Article

867

Drug-Eluting Stents for Saphenous Vein Graft Lesions: The Limits of Evidence

868

Drug-eluting stents for the treatment of bifurcation lesions: A randomized comparison between paclitaxel and sirolimus stents

869

Drug-eluting stents in diabetics & Complex patient groups

870

Drug-Eluting Stents in Heart Transplant Recipients

871

Drug-Eluting Stents in the Treatment of Intermediate Lesions: Pooled Analysis From Four Randomized Trials Original Research Article

872

Drug-eluting stents in total coronary occlusions: Another piece of the puzzle solved?

873

Drug-eluting stents in vascular intervention

874

Drug-Eluting Stents Versus Bare Metal Stents for Narrowing in Saphenous Vein Grafts

875

Drug-Eluting Stents Versus Bare Metal Stents in Percutaneous Coronary Interventions (A Meta-Analysis)

876

Drug-Eluting Stents Versus Bilateral Internal Thoracic Grafting for Multivessel Coronary Disease

877

Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Patients with Diabetes Mellitus

878

Drug-eluting stents vs bare metal stents for the treatment of large coronary vessels

879

Drug-eluting stents, 5-sirolimus stents and oral rapamycin

880

Drug-eluting stents: A multidisciplinary success story

881

Drug-eluting stents: an innovative multidisciplinary drug delivery platform

882

Drug-eluting stents: Beyond the hyperbole

883

Drug-eluting stents: Factors governing local pharmacokinetics

884

Drug-eluting stents: Failures and restenosis

885

Drug-eluting stents: insights into safety and indications

886

Drug-eluting stents: is new necessarily better?

887

Drug-Eluting Stents: Is Their Future as Bright as Their Past?

888

Drug-eluting stents: Lesion subsets

889

Drug-Eluting Stents: Life Insurance With a Better Death Benefit

890

Drug-eluting stents: Miscellaneous

891

Drug-eluting stents: Patient and lesion subsets

892

Drug-eluting stents: Registries and trials

893

Drug-eluting stents: Registries and trials

894

Drug-eluting stents: results, promises and problems

895

Drug-eluting stents: some bare facts

896

Drug-Eluting Versus Bare Metal Stents for Saphenous Vein Graft Intervention

897

Drug-evaluation harmonisation will lead to fewer animal tests

898

Drug-exposed infant cases in juvenile court: risk factors and court outcomes

899

Drug-Facilitated Effects on Protective Airway Reflexes During Out-of-Hospital Endotracheal Intubation

900

Drug-free in vitro activation and autologous transplantation in infertile women with diminished ovarian reserve: An experimental pilot study

901

Drugging Drug Resistance

902

Drugging the Bad “AKT-TOR” to Overcome TKI-Resistant Lung Cancer

903

Drugging the Undruggable

904

Drug–GSH interaction on GSH–Au modified electrodes: A cyclic voltammetry and electrochemical impedance spectroscopy study

905

Drug-hormone interactions on neurobehavioral responses in human neonates

906

Drug-induced Acute Interstitial Nephritis Pathology, Pathogenesis, and Treatment

907

Drug-induced amnesia impairs implicit relational memory

908

Drug-induced and toxic myopathies

909

Drug-Induced Apnea in Children Admitted to Loghman Hakim Hospital, Tehran, Iran

910

Drug-induced atrial fibrillation Review Article

911

Drug-induced atrioventricular block: prognosis after discontinuation of the culprit drug Original Research Article

912

Drug-induced autoimmunity

913

Drug-Induced Brugada Syndrome in Children: Clinical Features, Device-Based Management, and Long-Term Follow-Up

914

Drug-Induced Bullous Pemphigoid: Rapid Resolution with Corticosteroid Therapy

915

Drug-Induced by Systemic Lupus Erythematosus Presenting as Recurrent Pericardial Effusion After Mitral Valve Repair

916

Drug-induced cholestasis

917

Drug-induced gingival overgrowth and its tentative pharmacotherapy

918

Drug-Induced Gingival Overgrowth in an 8-Year-Old Girl: A Case Report

919

Drug-induced headaches

920

Drug-induced headaches

921

Drug-induced heart failure

922

drug-induced hemophagocytosis

923

Drug-induced hepatocellular liver injury due to benzylpenicillin with evidence of lymphocyte sensitization

924

Drug-induced hyperkalemia

925

Drug-induced hyperkalemia: old culprits and new offenders

926

Drug-induced hyperkalemia: The reply:

927

Drug-Induced Hypersensitivity Syndrome (DRESS) by Phenobarbital - Case Report and Literature Review

928

Drug-Induced Hypersensitivity Syndrome Caused by Carbamazepine Used for the Treatment of Trigeminal Neuralgia

929

Drug-induced interstitial nephritis in a child with idiopathic nephrotic syndrome

930

Drug-Induced Lichen Planus

931

Drug-Induced Linear Immunoglobulin-A Bullous Dermatosis

932

Drug-induced liver diseases

933

Drug-induced liver injury following positive drug rechallenge

934

Drug-Induced Long QT Syndrome and Exome Sequencing: Chinese Shadows Link Past and Future

935

Drug-Induced Lupus Erythematosus

936

Drug-induced lupus erythematosus

937

Drug-induced methemoglobinemia during thoracoscopic lung biopsy

938

Drug-induced myocardial infarction in young patients: Report of two cases

939

Drug-induced Nephrotoxicity and Medicinal Plants

940

Drug-induced neurological disorders : by K.K. Jain, 1996, Hogrefe & Huber Publishers, Seattle, USA, 389 pages, US$ 79, ISBN 0-88937-154-7

941

Drug-Induced Pemphigoid:: Bullous and Cicatricial

942

Drug-Induced Pemphigus

943

Drug-induced QT interval prolongation after ciprofloxacin administration in a patient receiving olanzapine

944

Drug-Induced QT Interval Prolongation and Torsade De Pointes:Identification of Risk Factors

945

Drug-induced renal disorders

946

Drug-Induced Scleroderma and Sclerodermiform Conditions

947

Drug-induced stabilisation of a mismatched C-T base pair in a DNA hairpin

948

Drug-induced systemic lupus erythematosus and TNF-α blockers

949

Drug-induced systemic lupus erythematosus and TNF-α blockers

950

Drug-induced systemic lupus erythematosus and TNF-α blockers

951

Drug-induced systemic lupus erythematosus associated with etanercept therapy

952

Drug-induced torsades de pointes in one patient with congenital long QT syndrome

953

Drug-Induced Toxic Epidermal Necrolysis

954

Drug-induced tremors

955

DRUG-INDUCED VASCULITIS IN A BREAST CANCER PATIENT RECEIVING CHEMOTHERAPY

956

Drug–lactose binding aspects in adhesive mixtures: Controlling performance in dry powder inhaler formulations by altering lactose carrier surfaces

957

Drug-licensing anomalies and Parkinsonʹs disease

958

Drug-loaded chondroitin sulfate-based nanogels: Preparation and characterization

959

Drug-loaded electrospun nanofibrous sheets as barriers against postsurgical adhesions in mice model

960

Drug-loaded polyelectrolyte microcapsules for sustained targeting of cancer cells

961

Drug-lunch alert

962

Drugmaker seeks permissions to collaborate on Cuban vaccine

963

Drug–protein interactions assessed by fluorescence measurements in the real complexes and in model dyads

964

Drug-related Death low Registration in Iran: A Mixed Method Approach for Causes, Recommendations to Solve This Problem and Geographical Evaluation of an Intervention

965

Drug-related deaths by region, sex, and age group per 100 injecting drug users in Scotland, 2000–01

966

Drug-related killings: a case of mistaken identity Review Article

967

Drug-related problems (DRPs) identified from geriatric medication safety review clinics

968

Drug-related Problems Among Type 2 Diabetic Patients With Hypertension in a Tertiary Care Hospital in Lebanon: A Cross-sectional Study

969

Drug‑related Problems in Hypertensive Patients: A Cross‑sectional Study from Indonesia

970

Drug-related Problems in Solid-Organ Transplant Recipients Hospitalized for COVID-19: An Experience of a Referral Tertiary Center in Iran

971

Drug-Resistance Associated Mutations in Polymerase (P) Gene of Hepatitis B Virus Isolated From Malaysian HBV Carriers

972

Drug-resistance genotyping in HIV-1 therapy: the VIRAD APT randomi sed controlled trial

973

Drug-resistant enteric fever in the UK

974

Drug-resistant epilepsy and epileptic phenotype-EEG association in MECP2 mutated Rett syndrome

975

Drug-resistant genotyping in HIV-1 therapy

976

Drug-resistant genotyping in HIV-1 therapy

977

Drug-resistant genotyping in HIV-1 therapy

978

Drug-resistant genotyping in HIV-1 therapy

979

Drug-resistant genotyping in HIV-1 therapy

980

Drug-resistant gonorrhoeae spread in the USA

981

Drug-Resistant Phosphatidylinositol 3-Kinase: Guidance for the Preemptive Strike

982

Drug-resistant Pneumocystis carinii

983

Drug-Resistant Proteus Virulence Factors Characterization and Their Inhibition Using Probiotic Bacteria

984

Drug-resistant pulmonary tuberculosis in western Turkey : Prevalence, clinical characteristics and treatment outcome

985

Drug-resistant strains of HIV increase sharply in Japan

986

Drug-resistant Streptococcus pneumoniae: rational antibiotic choices

987

Drug-resistant tuberculosis

988

Drug-Resistant Tuberculosis and Group 5 Anti-Tuberculosis Drugs

989

Drug-resistant tuberculosis in Taipei, 1996-1999

990

Drug-resistant tuberculosis: desperate measures?

991

Drugs & devices in brief

992

Drugs against superbugs: private lessons from bacteriophages

993

Drugs and a dark future

994

Drugs and Addictive Behaviour: A Guide to Treatment (3rd edition): Hamid Ghodse, Cambridge University Press 2002. £39.95, 520 pages

995

Drugs and demons

996

Drugs and mental health

997

Drugs and narcotics in history : Edited by Roy Porter and Mikulas Teich. Cambridge University Press, Cambridge, 1995. xii + 227 pp., U.S.$49.95 (cloth)

998

Drugs and nutrition: how side effects can influence nutritional intake

999

Drugs and nutrition: Important drug-nutrient interactions

1000

Drugs and personal care products as ubiquitous pollutants: occurrence and distribution of clofibric acid, caffeine and DEET in the North Sea

بازگشت